Sanofi-Aventis Settles Antitrust Case Over Insulin Pen Monopoly Allegations
Sanofi-Aventis US has reached a settlement in a significant antitrust litigation case that accused the pharmaceutical giant of attempting to stifle competition for its single-use insulin injector pens. The settlement, reached with a group of drug wholesalers, was announced to a Massachusetts federal court, avoiding a trial that could have widely influenced the legal landscape…